Attached files
file | filename |
---|---|
10-K - Predictive Oncology Inc. | v177566_10k.htm |
EX-31.1 - Predictive Oncology Inc. | v177566_ex31-1.htm |
EX-23.1 - Predictive Oncology Inc. | v177566_ex23-1.htm |
Exhibit
32.1
CERTIFICATION
OF PRINCIPAL EXECUTIVE OFFICER
AND
PRINCIPAL FINANCIAL OFFICER
PURSUANT
TO 18 U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO SECTION 906
OF THE
SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report on Form 10-K of BioDrain Medical, Inc. (the
"Company") for the year ended December 31, 2009 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, Kevin R. Davidson.,
Chief Executive Officer and Chief Financial Officer, of the Company, certify,
pursuant to § 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1350, that to
my knowledge:
(1) The
Report fully complies with the requirements of Section 13(a) of the Securities
Exchange Act of 1934 (15 U.S.C. 78m); and
(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
Date:
March 31, 2010
/s/ Kevin
R. Davidson
Kevin R.
Davidson
Chief
Executive Officer and Chief Financial Officer
(Principal
Executive Officer and Principal Financial Officer)